Allinaire Therapeutics

Allinaire Therapeutics develops novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.

Funding: BioCrossroads, Indiana University’s Innovate Indiana Fund

Stage: Preclinical